CHPA Statement on Passage of Microbead-Free Waters Act of 2015

WASHINGTON–(BUSINESS WIRE)–Consumer Healthcare Products Association (CHPA) President and CEO Scott
Melville released the following statement today, commending the U.S.
House of Representatives for swift passage of the Microbead-Free Waters
Act of 2015 (H.R. 1321). The bill, sponsored by U.S. Rep. Frank Pallone,
Jr. (D-N.J.) and U.S. Rep. Fred Upton (R-Mich.), provides a feasible
timeframe for the removal of synthetic plastic microbeads from
over-the-counter (OTC) and personal care products.

The bill cleared the House today without objection after previously
passing the House Energy and Commerce Committee, also without objection,
on November 18.

“The OTC medicine industry applauds Representatives Pallone and Upton
for shepherding legislation that sets forth feasible phase-out dates for
plastic microbeads in OTC products, appropriate definitions of key
terms, and ensuring uniform enforcement across the nation.

“Our industry takes concerns about these solid plastic microbeads
possibly entering the marine environment very seriously, and we are
committed to reformulating cosmetic OTCs – such as acne face washes and
toothpastes – to remove plastic microbeads. CHPA member companies have
already taken steps to voluntarily remove these solid plastic microbeads
from their products by ceasing the development of any new products
containing synthetic plastic microbeads and working toward formulating
replacement products. The timeframe allocated in this bill provides
manufacturers adequate time to identify and phase in alternatives.”

CHPA along with the American Chemistry Council, Personal Care Products
Association, and SPI: The Plastics Industry Trade Association sent a letter
of support for the legislation to Reps. Upton and Pallone on Nov. 17.

The Consumer Healthcare Products Association (CHPA) is the
134-year-old trade association representing the leading manufacturers
and marketers of over-the-counter (OTC) medicines and dietary
supplements. Every dollar spent by consumers on OTC medicines saves the
U.S. healthcare system $6-$7, contributing a total of $102 billion in
savings each year. CHPA is committed to promoting the increasingly vital
role of over-the-counter medicines and dietary supplements in America’s
healthcare system through science, education, and advocacy.


Jenni Roberson, 202-429-9260